COMPANY UPDATEFY 2017 AUDITED

PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK

This presentation is made to provide information. No representation or warranty ismade as to the fairness, accuracy, completeness or correctness of the information,opinions and conclusions contained within this presentation. All information includingbusiness forward plans in this presentation should not be considered as arecommendation in relation to holding purchasing or selling shares in any jurisdiction.No copy or use of this presentation should occur without the permission of PT INDUSTRIJAMU DAN FARMASI SIDO MUNCUL TBK.

Disclaimer

INTRODUCTION

FINANCIAL HIGHLIGHT

DESCRIPTION 2016 2017 ∆AUDITED AUDITED

Net Sales 2,561,806 2,573,840 0.5%Operating Income 559,443 625,738 11.9%

% margin 21.8% 24.3%Net Income 480,525 533,799 11.1%

% margin 18.8% 20.7%

Total Assets 2,987,614 3,158,198 5.7%Total Liabilities 229,729 262,333 14.2%Total Equity 2,757,885 2,895,865 5.0%

Working Capital 1,578,439 1,420,394 -10.0%

Current Ratio 8.3 7.8 -0.5Cash Conversion Cycle 85 96 11Debt to Equity 0.0% 0.0% 0.0%

PROFILE

VISIONTo become a leading herbal medicine, health food & drinks, and herbal ingredient

processing company which can benefit the community and environment

MISSION To develop rational, safe and honest herbal-based products based on research. To continuously develop research in herbal medicines. To assist and encourage the government, education institutions, and medical sector to

play a more important role in research and development of herbal medicines andmedication .

To increase community awareness of them importance of maintaining health throughhealthy living pattern, use of natural substance, and naturopathy medication.

To implement intensive corporate social responsibility (CSR) To manage an environmental-oriented company. To become a world class herbal medicine company

BUSINESS FIELDSHerbal Medicine & Pharmaceutical

MILESTONES

1970A limited

partnership wasestablished

under the nameCV. Industri Jamu

& Farmasi SidoMuncul

1975PT. Industri Jamu& Farmasi Sido

Munculestablished

1984The factory was

moved toKaligawe,Semarang

2000Inaugurated anew factory in

Klepu, Ungaran

2010Herbal extraction

factory groundbreaking

2013IPO on the

Indonesia StockExchange

2014Acquisition of PT

Berlico MuliaFarma

1951A small businesswas establishedunder the name

Sido Munculwhich has the

meaning of“Dream Comes

True”

EVENT: 2017 - NOW

CORPORATE STRUCTURE

SUBSIDIARIES

No. Subsidiaries EquityParticipation

Year ofParticipation

BusinessLines

Operational

1 PT Muncul Mekar 99,99% 2012 Trading A distribution company of allSido Muncul productsthrough an extensivedistribution network spreadall over Indonesia.

2 PT Semarang HerbalIndo Plant

99,99% 2012 HerbExtraction

A raw material extractionfactory

3 PT Berlico MuliaFarma

99,99% 2014 Pharmacy A pharmaceutical company,producing OTC and Ethicalproducts

4 Muncul NigeriaLimited

99,00% 2018 Export New entity in Nigeria, whichwill support marketingefforts in expanding exportsales in Nigeria.

BOARD MEMBERS

BOARD OF DIRECTORS

Jonatha Sofyan Hidayat President DirectorIrwan Hidayat DirectorDavid Hidayat DirectorVenancia Sri Indrijati W. DirectorCarlo Lukman Windarto Independent Director

BOARD OF COMMISSIONERS

Sigit Hartojo Hadi Santoso President Commissioner

Johan Hidayat CommissionerEric Marnandus Independent CommissionerRonnie Behar Independent Commissioner

BUSINESS OVERVIEW

PRODUCT PORTFOLIO

HERBAL&

SUPPLEMENT

FOOD&

BEVERAGES

PHARMACEUTICAL

DISTRIBUTION NETWORK

INTERNATIONAL BUSINESS

SIDO MUNCUL PRODUCTS ARE EXPORTEDTO SEVERAL COUNTRIES Malaysia Singapore Brunei Darussalam Hong Kong Taiwan Korea Selatan Australia Saudi Arabia Pakistan Nigeria Togo USA Canada

FINANCIAL OVERVIEW

2016 2017

SALES (IDR Bn)

SALES MIX

Consolidated+0.5%

Herbal &Supplement+11.3%

Food &Beverages-17.5%

Pharma-17.5%

Herbal &Supplement

66%

Food &Beverage

31%

Pharma3%

2,561.8 2,573.8

559626

21.8% 24.3%

2016 2017

Op. Profit % to NS

OPERATING PERFORMANCE (IDR Bn)

GROSS PROFIT

OPEX to Net Sales

14.5% 14.2%

5.4% 6.7%

2016 2017

%OPEX to NSMarketing Exp. G&A Exp.

OPERATING PROFIT

Consolidated+11.9%

1,068 1,162

41.7% 45.1%

2016 2017Gross Profit % to NS

Consolidated+8.8%

NET EARNINGS (IDR Bn)

NET INCOME

481534

18.8% 20.7%

2016 2017

Net Income % to NS

Consolidated+11.1%

PROFITABILITY

DIVIDEND PER SHARE

16.1% 16.9%

17.4% 18.4%

2016 2017

ROA ROE

27 24 25 26

100%86% 85% 82%

2013 2014 2015 2016

DPS %payout

FINANCIAL POSITION (IDR Bn)

ASSETS & EQUITY

2,955 2,820 2,796 2,988 3,158

2,614 2,625 2,598 2,758 2,896

2013 2014 2015 2016 2017

ASSETS EQUITY

0.0 0.0 0.0 0.0 0.0

2013 2014 2015 2016 2017

DEBT POITION

CASH CYCLE

79 7886 85

96

2013 2014 2015 2016 2017

BUSINESS PROSPECTS

BUSINESS PROSPECTS

In early of 2018, Muncul NigeriaLimited established to increase thepotential export market in Africaarea.

New production facility of liquid herbalmedicine, very modern and fullyautomated.

Production capacity will rise 100% whichwill be used to produce other kinds ofherbal products.

PT INDUSTRI JAMU DAN FARMASISIDO MUNCUL TBK.

HEAD OFFICE:Gedung Menara Suara Merdeka, Lt. 16Jalan Pandanaran No. 30Semarang - Indonesia

FACTORY:Jl. Soekarno Hatta, Km. 28Kec. Bergas – KlepuSemarang – Indonesia

BRANCH OFFICE:

Grha Muncul MekarJl. Panjang Arteri Kelapa Dua, No. 27Kebon JerukJakarta Barat - Indonesia

CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

in IDR Mn 2017 2016AUDITED AUDITED

Current AssetsCash and Cash Equivalents 902,852 1,002,135 -9.9%Trade Receivables 427,322 367,204 16.4%Inventories - Net 267,915 317,082 -15.5%Others 30,812 107,704 -71.4%Total Current Assets 1,628,901 1,794,125 -9.2%Total Non-current Assets 1,529,297 1,193,489 28.1%TOTAL ASSETS 3,158,198 2,987,614 5.7%Current LiabilitiesTrade Payables 124,898 177,864 -29.8%Others 83,609 37,822 121.1%Total Current Liabilities 208,507 215,686 -3.3%Total Non-current Liabilites 53,826 14,043 283.3%TOTAL LIABILITIES 262,333 229,729 14.2%EQUITYEquity Attributable to Owners of the Parent Entity 2,895,858 2,757,878 5.0%Non-controlling Interest 7 7 0.0%TOTAL EQUITY 2,895,865 2,757,885 5.0%TOTAL LIABILITIES AND EQUITY 3,158,198 2,987,614 5.7%

∆

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

in IDR Mn 2017 2016AUDITED AUDITED

Sales 2,573,840 2,561,806 0.5%Cost of Good Sold 1,411,881 1,494,142 -5.5%Gross Profit 1,161,959 1,067,664 8.8%

% Margin 45.1% 41.7% 3.5%Selling Expenses 364,203 370,195 -1.6%General and Administrative Expenses 172,018 138,026 24.6%Operating Income 625,738 559,443 11.9%

% Margin 24.3% 21.8% 2.5%Other Finance Income 42,241 50,945 -17.1%Other Finance Expenses 588 140 320.0%Other Operating Income 17,436 23,381 -25.4%Other Operating Expenses 2,938 4,547 -35.4%Income Before Tax 681,889 629,082 8.4%

% Margin 26.5% 24.6% 1.9%Income Tax Expenses 148,090 148,557 -0.3%Net Income for the Year 533,799 480,525 11.1%

% Margin 20.7% 18.8% 2.0%Other Comprehensive Income (Loss) (11,080) (8,803) 25.9%Total Comprehensive Income for the Year 522,719 471,722 10.8%

% Margin 20.3% 18.4% 1.9%

∆

CONSOLIDATED STATEMENTS OF CASH FLOWS

in IDR Mn 2017 2016AUDITED AUDITED

Cash Flows From Operating Activities 640,695 462,656Cash Flows From Investing Activities (350,264) 9,402Cash Flows From Financing Activities (384,739) (312,151)

Net Increase (Decrease) in Cash and Cash Equivalents (94,308) 159,907Effect of Changes in Foreign Exchange Rate 25 253Cash and Cash Equivalents At the Beginning of the Year 997,135 836,975Cash and Cash Equivalents At the End of the Year 902,852 997,135